 |
| CLICK HERE TO VIEW CURRENT ISSUE |
 |
| Best of NAMA 2026 |
|
 |
|
BAYER ANNOUNCES AGREEMENTS TO RESOLVE MAJOR LEGACY MONSANTO LITIGATION
Jun. 25, 2020
Source: Bayer news release
Leverkusen, June 24, 2020 - Bayer announced today a series of agreements that will substantially resolve major outstanding Monsanto litigation, including U.S. Roundup™ product liability litigation, dicamba drift litigation and PCB water litigation.
The main feature is the U.S. Roundup™ resolution that will bring closure to approximately 75% of the current Roundup™ litigation involving approximately 125,000 filed and unfiled claims overall. The resolved claims include all plaintiff law firms leading the Roundup™ federal multi-district litigation (MDL) or the California bellwether cases, and those representing approximately 95% of the cases currently set for trial, and establish key values and parameters to guide the resolution of the remainder of the claims as negotiations advance. The resolution also puts in place a mechanism to resolve potential future claims efficiently.
The company will make a payment of $8.8 billion to $9.6 billion to resolve the current Roundup™ litigation, including an allowance expected to cover unresolved claims, and $1.25 billion to support a separate class agreement to address potential future litigation. The Roundup™ class agreement will be subject to approval by Judge Vince Chhabria of the U.S. District Court for the Northern District of California. The resolutions were approved unanimously by Bayer's Board of Management and Supervisory Board with input from its Special Litigation Committee. The agreements contain no admission of liability or wrongdoing.
"First and foremost, the Roundup™ settlement is the right action at the right time for Bayer to bring a long period of uncertainty to an end," said Werner Baumann, Chief Executive Officer of Bayer. "It resolves most current claims and puts in place a clear mechanism to manage risks of potential future litigation. It is financially reasonable when viewed against the significant financial risks of continued, multi-year litigation and the related impacts to our reputation and to our business.
"The decision to resolve the Roundup™ litigation enables us to focus fully on the critical supply of healthcare and food. It will also return the conversation about the safety and utility of glyphosate-based herbicides to the scientific and regulatory arena and to the full body of science."
"The Roundup™ agreements are designed as a constructive and reasonable resolution to a unique litigation," said Kenneth R. Feinberg, court-appointed mediator for the settlement talks. "The separate, independent settlements of the current claims are unique and a tribute to Bayer. The significant progress made to date - which exceeds the initial participation rates of other claims resolution proceedings - provides a robust framework that will enable the parties to bring closure to the current Roundup™ litigation in due course."
To read the entire news release click here.
|
|
|
|
|
